Common Myths About Women and Heart Disease, Examined

This myth has real consequences: studies consistently show that women are less likely than men to be referred for cardiac testing and, when hospitalized for a heart attack, are less likely to receive guideline-recommended treatments promptly. The biology also differs — women tend to develop heart disease about a decade later than men on average, partly due to the protective effects of estrogen, but that delay does not mean immunity. Understanding that heart disease looks different in women than in men is a critical first step toward closing this care gap.

The Hollywood image of a heart attack — someone grabbing their chest and collapsing — reflects a pattern more common in men. Women's symptoms are frequently subtler and easier to attribute to stress, indigestion, or the flu. This mismatch contributes to women waiting longer before seeking emergency care. Knowing the full range of possible symptoms can be the difference between timely treatment and irreversible damage. If something feels wrong, trust that instinct and seek evaluation promptly.

Estrogen has a meaningful protective effect on blood vessels, helping to keep them flexible and supporting healthy cholesterol levels. When estrogen declines sharply at menopause, that protective buffer diminishes. Blood pressure tends to rise, LDL (low-density lipoprotein, often called "bad" cholesterol) often increases, and arterial stiffness can worsen. The post-menopausal years are therefore an especially important time to monitor cardiovascular health markers with a healthcare provider — not a time to assume the hard work of prevention is behind you.

High blood pressure, chronic inflammation, insulin resistance, a sedentary lifestyle, smoking, and chronic stress all independently raise cardiovascular risk — regardless of cholesterol levels. Some women also have a condition called microvascular disease, where small coronary arteries are affected rather than the large ones typically detected by standard tests. This is one reason why a full risk assessment from a healthcare provider, not a single lab value, gives the clearest picture of heart health.

Reproductive health history is increasingly understood as a window into long-term cardiovascular health. Women who experienced preeclampsia during pregnancy, for example, face a higher lifetime risk of hypertension and heart disease. Similarly, polycystic ovary syndrome (PCOS) is linked to elevated cardiovascular risk even in younger women. Tracking these connections across a woman's full health history — and sharing that history with providers — helps build a more complete risk picture earlier in life.